FDA Inspection 1299058 — Peter C. Boldingh, Pharm.D
The FDA completed an inspection of Peter C. Boldingh, Pharm.D on Jan 9, 2026 in Dilworth, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 9, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Dilworth, MN (United States)
Additional details
Clinical BA/BE